SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or
15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): December 1995
BIOPHARMACEUTICS, INC.
(Exact name of Registrant as specified in its Charter)
DELAWARE 1-9370 13-3186327
(State or other (Commission File Number) (I.R.S Employer
jurisdiction of I.D. Number)
incorporation)
990 Station Road
Bellport, New York 11713
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (516)286-5800
N/A
(Former name or former address, if changed since last report.)
1
<PAGE>
Item 5. Other Events
By court order dated November 17, 1995, the United States District
Court for the Eastern District of New York reduced the fine imposed in the
original judgment and probation commitment order dated August 22, 1989 against
Patient Medical Systems Corp. (now known as Biopharmaceutics, Inc.) to $50,000,
from an original amount of $175,000, payable $25,000 on or before December 13,
1995 and $25,000 payable on May 13, 1996. In the event that the Company fails to
timely make any of the payments specified, the fine shall be increased to
$163,000 with interest from August 22, 1989.
EXHIBIT INDEX
Current Report on Form 8-K
of
Biopharmaceutics, Inc.
Date of Report: December 1, 1995
Exhibits:
28.8 Court order dated November 17, 1995 (Order received November 27, 1995)
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BIOPHARMACEUTICS, INC.
(Registrant)
By: /s/ Edward Fine
--------------------
Edward Fine
President, Chief Executive Officer
(Signature)
Dated: December 1, 1995
3
<PAGE>
